(TheNewswire)
Winnipeg, June 4, 2024. - TheNewswire - Cytophage TechnologiesLtd. ( TSXV:CYTO ) (“ Cytophage ” or the “Company”), the only publicly traded phage companythat is focused on bacteriophage solutions for both animal health andhuman health, is pleased to announce that its CEO Dr. StevenTheriault, is set to present at TEDx Winnipeg on June 6, 2024, at thePrairie Theatre Exchange. Dr. Theriault’s topic, highly relevant totoday’s antibiotic resistant world, is ‘Bacteriophages as thesilent cure to antimicrobial resistance’ (AMR).
TEDx events offer an intriguing mix of scientists, entrepreneurs andartists that have one thing in common - they bring forwarddisruptive ideas in their respective sectors, challenging establishedconcepts and encouraging new perspectives and thinking. Dr. Theriault,who has a PhD in molecular genetics andvirology and 15 years experience at Canada’s National MicrobiologyLab, is a uniquely qualified presenter. He is atthe forefront of the global battle against antibiotic resistant“superbugs”. His company, Cytophage, and its team of scientists,develop highly specific bacteriophages, viruses that destroy harmfulbacteria.
With more attention on the threat of AMR in the media, and the WorldHealth Organization identifying AMR as one of the top global publichealth and development threats 1 , thesearch for viable solutions is an opportune topic for a TED event.
“The worldwide overuse ofantibiotics and increased globalization has created the next humanhealth catastrophe in which resistant bacteria are spreading fasterthan at any other time in history”, commented CEO Dr. StevenTheriault. “Cytophage is truly meeting the moment by developingphages that can uniquely combat bacteria strains that have becomeresistant to antibiotics. I am thrilled todiscuss our innovative phage technology and its potential applications with an ever-growing TEDxaudience.”
TEDx is the grassroots TED initiative with the missionto discover “ideas worth spreading,” with talks from localspeakers who share ideas that help people understand and navigate theworld. Volunteers from the local community organize a TEDx event, andjust like TED events, its goal is to spark conversation, connection,and community. All TEDx Winnipeg speakers and organizers arevolunteers who are committed to developing and building innovativeideas. More information about the TEDx Winnipeg event is available athttps://tedxwinnipeg.ca/.
For further information pleasecontact:
Heather Medwick
Chief Operating Officer
heather@cytophage.com
431 388 8873
Cytophage Investor Alerts: https://cytophage.com/subscribe/
About Cytophage Technologies
Cytophage Technologies ( TSXV:CYTO ) is apioneering biotechnology company dedicated to bacteriophage research,product development and commercialization. Committed to addressing theglobal challenge of antibiotic resistance, Cytophage advancesinnovative products that harness the power of bacteriophages to combatbacterial infections affecting human health, animal health, and foodsecurity.
Cautionary Statement onForward-Looking Information
This news release contains “forward-lookinginformation” and “forward-looking statements” (collectively,“forward-looking statements”) within the meaning of the applicableCanadian securities legislation. All statements, other than statementsof historical fact, are forward-looking statements and are based onexpectations, estimates and projections as at the date of this newsrelease. Any statement that involves discussions with respect topredictions, expectations, beliefs, plans, projections, objectives,assumptions, future events or performance (often but not always usingphrases such as “expects”, or “does not expect”, “isexpected”, “anticipates” or “does not anticipate”,“plans”, “budget”, “scheduled”, “forecasts”,“estimates”, “believes” or “intends” or variations of suchwords and phrases or stating that certain actions, events or results“may” or “could”, “would”, “might” or “will” betaken to occur or be achieved) are not statements of historical factand may be forward-looking statements. Forward-looking statementsinvolve known and unknown risks, uncertainties and other factors whichmay cause the actual results, performance or achievements of Cytophageto be materially different from any future results, performance orachievements expressed or implied by the forward-looking statements.Factors that could cause actual results to differ materially fromthose anticipated in these forward-looking statements are
described under the caption “Risk Factors” inCytophage’s Filing Statement dated January 30, 2024, which isavailable for view on SEDAR+ at www.sedarplus.ca. These risks includebut are not limited to, the risks associated with the bacteriophageindustry, such as operational risks in development or capitalexpenditures, the uncertainty of extensive regulatory approvalrequirements, government regulations, protection of intellectualproperty, product liability and rapid technological advancements.Forward-looking statements contained herein are made as of the date ofthis press release, and Cytophage disclaims, other than as required bylaw, any obligation to update any forward-looking statements whetheras a result of new information, results, future events, circumstances,or if management’s estimates or opinions should change, or otherwise. There can be no assurance that forward-lookingstatements will prove to be accurate, as actual results and futureevents could differ materially from those anticipated in suchstatements. Accordingly, the reader is cautioned not to place unduereliance on forward-looking statements.
Neither the TSXV nor its RegulationServices Provider (as that term is defined in the policies of theTSXV) accepts responsibility for the adequacy or accuracy of this newsrelease.
1 https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
Copyright (c) 2024 TheNewswire - All rights reserved.